Zosyn (Cardinal Health)


Welcome to the PulseAid listing for the Zosyn drug offered from Cardinal Health. This beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: piperacillin sodium and tazobactam sodium
SUBSTANCE NAME: TAZOBACTAM SODIUM; PIPERACILLIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-11-01
END MARKETING DATE: 0000-00-00


Zosyn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZosyn from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: .375; 3(g/15mL; g/15mL)
START MARKETING DATE: 1993-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-4228_db7aa1c2-22e6-492f-81ba-5ecbb8836ac0
PRODUCT NDC: 55154-4228
APPLICATION NUMBER: NDA050684

Other TAZOBACTAM SODIUM; PIPERACILLIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthZosyn
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Zosyn